17 results on '"Chang, Jan-Gowth"'
Search Results
2. Clinical application of liquid biopsy in cancer patients
- Author
-
Chang, Chieh-Min, Lin, Kuei-Ching, Hsiao, Nien-En, Hong, Wei-An, Lin, Chia-Yu, Liu, Ta-Chih, Chang, Ya-Sian, and Chang, Jan-Gowth
- Published
- 2022
- Full Text
- View/download PDF
3. Mutation profile of non-small cell lung cancer revealed by next generation sequencing
- Author
-
Chang, Ya-Sian, Tu, Siang-Jyun, Chen, Yu-Chia, Liu, Ting-Yuan, Lee, Ya-Ting, Yen, Ju-Chen, Fang, Hsin-Yuan, and Chang, Jan-Gowth
- Published
- 2021
- Full Text
- View/download PDF
4. A novel miRNA-based classification model of risks and stages for clear cell renal cell carcinoma patients
- Author
-
Dessie, Eskezeia Y., Tsai, Jeffrey J. P., Chang, Jan-Gowth, and Ng, Ka-Lok
- Published
- 2021
- Full Text
- View/download PDF
5. Identification of most influential co-occurring gene suites for gastrointestinal cancer using biomedical literature mining and graph-based influence maximization
- Author
-
Wang, Charles C. N., Jin, Jennifer, Chang, Jan-Gowth, Hayakawa, Masahiro, Kitazawa, Atsushi, Tsai, Jeffrey J. P., and Sheu, Phillip C.-Y.
- Published
- 2020
- Full Text
- View/download PDF
6. Whole genome and RNA sequencing analyses for 254 Taiwanese hepatocellular carcinomas.
- Author
-
Chang, Ya-Sian, Tu, Siang-Jyun, Chen, Hong-Da, Chung, Chin-Chun, Hsu, Ming-Hon, Chou, Yu-Pao, Lee, Ya-Ting, Yen, Ju-Chen, Jeng, Long-Bin, and Chang, Jan-Gowth
- Subjects
RNA sequencing ,WHOLE genome sequencing ,NUCLEOTIDE sequencing ,HEPATOCELLULAR carcinoma ,ALTERNATIVE RNA splicing ,GENE expression - Abstract
Background: Comprehensive and integrative analysis of hepatocellular carcinoma (HCC) is important. In this study, we explored Taiwanese HCCs using multi-omics analyses. Methods: We analyzed 254 HCCs by whole genome sequencing and total RNA sequencing, and then used bioinformatic tools to analyze genomic and transcriptomic alterations in coding and non-coding sequences to explore the clinical importance of each sequence. Results: The frequencies of the five most commonly mutated cancer-related genes were TERT, TP53, CTNNB1, RB1, and ARID1A. Genetic alteration frequencies influenced the etiology of HCC; some alterations were also correlated with clinicopathological conditions. Many cancer-related genes had copy number alterations (CNAs) and structure variants (SVs) that changed according to etiology and exhibited potential associations with survival. We also identified several alterations in histone-related genes, HCC-related long non-coding RNAs, and non-coding driver genes that may contribute to the onset and progression of HCC. Transcriptomic analysis revealed that 229 differentially expressed and 148 novel alternative splicing (AS) genes, as well as the presence of fusion genes, were associated with patient survival. Moreover, somatic mutations, CNAs, and SVs were associated with immune checkpoint gene expression and tumor microenvironment. Finally, we identified relationships among AS, immune checkpoint gene expression and tumor microenvironment. Conclusions: This study shows that genomic alterations are associated with survival, including DNA-based and RNA-based data. Moreover, genomic alterations and their associations with immune checkpoint genes and the tumor microenvironment may provide novel insights for the diagnosis and treatment of HCC. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome
- Author
-
Yang, Chin-An, Bauer, Sandra, Ho, Yu-Chen, Sotzny, Franziska, Chang, Jan-Gowth, and Scheibenbogen, Carmen
- Published
- 2018
- Full Text
- View/download PDF
8. Next-generation sequencing profiling of mitochondrial genomes in gout
- Author
-
Tseng, Chia-Chun, Chen, Chung-Jen, Yen, Jeng-Hsien, Huang, Hsi-Yuan, Chang, Jan-Gowth, Chang, Shun-Jen, and Liao, Wei-Ting
- Published
- 2018
- Full Text
- View/download PDF
9. Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2.
- Author
-
Pei-Chin Lin, Hsien-Da Huang, Chun-Chi Chang, Ya-Sian Chang, Ju-Chen Yen, Chien-Chih Lee, Wen-Hsin Chang, Ta-Chih Liu, Jan-Gowth Chang, Lin, Pei-Chin, Huang, Hsien-Da, Chang, Chun-Chi, Chang, Ya-Sian, Yen, Ju-Chen, Lee, Chien-Chih, Chang, Wen-Hsin, Liu, Ta-Chih, and Chang, Jan-Gowth
- Subjects
CANCER treatment ,NON-small-cell lung carcinoma ,NON-coding RNA ,NUCLEOTIDE sequencing ,DOWNREGULATION ,NEOPLASTIC cell transformation ,RNA metabolism ,BIOCHEMISTRY ,CELL lines ,CELL physiology ,GENES ,LUNG cancer ,LUNG tumors ,PHENOMENOLOGY ,RNA ,SURVIVAL analysis (Biometry) ,SEQUENCE analysis - Abstract
Background: Long noncoding RNAs (lncRNAs) play crucial roles in tumorigenesis, and lncRNA taurine-upregulated gene 1 (TUG1) has been proven to be associated with several human cancers. However, the mechanisms of TUG1-involved regulation remain largely unknown.Methods: We examined the expressions of TUG1 in a cohort of 89 patients with non-small cell lung cancer (NSCLC) to determine the association between TUG1 expression and clinical parameters. We used circular chromosome conformation capture (4C) coupled with next-generation sequencing to explore the genome regions that interact with TUG1 and the TUG1-mediated regulation.Results: TUG1 was significantly downregulated, and the TUG1 downregulation correlated with sex (p = 0.006), smoking status (p = 0.016), and tumor differentiation grade (p = 0.001). Knockdown of TUG1 significantly promoted the proliferation of NSCLC cells. According to the bioinformatic analysis result of TUG1 4C sequencing data, 83 candidate genes and their interaction regions were identified. Among these candidate genes, CUGBP and Elav-like family member 1 (CELF1) are potential targets of TUG1 in-trans regulation. To confirm the interaction between TUG1 and CELF1, relative expressions of CELF1 were examined in TUG1 knockdown H520 cells; results showed that CELF1 was significantly upregulated in TUG1 knockdown H520 cells. RNA immunoprecipitation was then performed to examine whether TUG1 RNA was bound to PRC2, a TUG1-involved regulation mechanism reported in previous studies. The results demonstrated that TUG1 RNA was bound to enhancer of zeste protein 2/embryonic ectoderm development (EZH2/EED), which is essential for PRC2. Finally, our designed ChIP assay revealed that the EZH2/EED was bound to the promotor region of CELF1 within 992 bp upstream of the transcript start site.Conclusion: TUG1 is downregulated in NSCLC. Using TUG1 4C sequencing and bioinformatic analysis, we found CELF1 to be a potential target of TUG1 RNA in in-trans regulation. Moreover, subsequent experiments showed that TUG1 RNA could bind to PRC2 in the promotor region of CELF1 and negatively regulate CELF1 expressions in H520 cells. Our results may facilitate developing new treatment modalities targeting TUG1/PRC2/CELF1 interactions in patients with NSCLC. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
10. MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression.
- Author
-
Cho, Shih-Feng, Chang, Yuli Christine, Chang, Chao-Sung, Lin, Sheng-Fung, Liu, Yi-Chang, Hsiao, Hui-Hua, Chang, Jan-Gowth, and Liu, Ta-Chih
- Published
- 2014
- Full Text
- View/download PDF
11. Squamocin modulates histone H3 phosphorylation levels and induces G1 phase arrest and apoptosis in cancer cells.
- Author
-
Lee, Chien-Chih, Lin, Yi-Hsiung, Chang, Wen-Hsin, Lin, Pei-Chin, Wu, Yang-Chang, and Chang, Jan-Gowth
- Abstract
Background: Histone modifications in tumorigenesis are increasingly recognized as important epigenetic factors leading to cancer. Increased phosphorylation levels of histone H3 as a result of aurora B and pMSK1 overexpression were observed in various tumors. We selected aurora B and MSK1 as representatives for testing various compounds and drugs, and found that squamocin, a bis-tetrahydrofuran annonaceous acetogenin, exerted a potent effect on histone H3 phosphorylation.Methods: GBM8401, Huh-7, and SW620 cells were incubated with 15, 30, and 60 μM squamocin for 24 h. The expressions of mRNA and proteins were analyzed by qRT-PCR and Western blotting, respectively. The cell viability was determined by an MTT assay. Cell cycle distribution and apoptotic cells were analyzed by flow cytometry.Results: Our results showed that squamocin inhibited the proliferation of GBM8401, Huh-7, and SW620 cells, arrested the cell cycle at the G1 phase, and activated both intrinsic and extrinsic pathways to apoptosis. In addition, we demonstrated that squamocin had the ability to modulate the phosphorylation levels of H3S10 (H3S10p) and H3S28 (H3S28p) in association with the downregulation of aurora B and pMSK1 expressions.Conclusions: This study is the first to show that squamocin affects epigenetic alterations by modulating histone H3 phosphorylation at S10 and S28, providing a novel view of the antitumor mechanism of squamocin. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
12. Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2.
- Author
-
Lin PC, Huang HD, Chang CC, Chang YS, Yen JC, Lee CC, Chang WH, Liu TC, and Chang JG
- Subjects
- CELF1 Protein metabolism, Carcinoma, Non-Small-Cell Lung pathology, Cell Line, Tumor, Cell Proliferation, Chromatin Immunoprecipitation, Female, Gene Expression Regulation, Neoplastic, High-Throughput Nucleotide Sequencing methods, Humans, Lung Neoplasms pathology, Male, Promoter Regions, Genetic, RNA, Long Noncoding metabolism, Survival Analysis, Transcriptional Activation, CELF1 Protein genetics, Carcinoma, Non-Small-Cell Lung genetics, Down-Regulation, Lung Neoplasms genetics, Polycomb Repressive Complex 2 metabolism, RNA, Long Noncoding genetics
- Abstract
Background: Long noncoding RNAs (lncRNAs) play crucial roles in tumorigenesis, and lncRNA taurine-upregulated gene 1 (TUG1) has been proven to be associated with several human cancers. However, the mechanisms of TUG1-involved regulation remain largely unknown., Methods: We examined the expressions of TUG1 in a cohort of 89 patients with non-small cell lung cancer (NSCLC) to determine the association between TUG1 expression and clinical parameters. We used circular chromosome conformation capture (4C) coupled with next-generation sequencing to explore the genome regions that interact with TUG1 and the TUG1-mediated regulation., Results: TUG1 was significantly downregulated, and the TUG1 downregulation correlated with sex (p = 0.006), smoking status (p = 0.016), and tumor differentiation grade (p = 0.001). Knockdown of TUG1 significantly promoted the proliferation of NSCLC cells. According to the bioinformatic analysis result of TUG1 4C sequencing data, 83 candidate genes and their interaction regions were identified. Among these candidate genes, CUGBP and Elav-like family member 1 (CELF1) are potential targets of TUG1 in-trans regulation. To confirm the interaction between TUG1 and CELF1, relative expressions of CELF1 were examined in TUG1 knockdown H520 cells; results showed that CELF1 was significantly upregulated in TUG1 knockdown H520 cells. RNA immunoprecipitation was then performed to examine whether TUG1 RNA was bound to PRC2, a TUG1-involved regulation mechanism reported in previous studies. The results demonstrated that TUG1 RNA was bound to enhancer of zeste protein 2/embryonic ectoderm development (EZH2/EED), which is essential for PRC2. Finally, our designed ChIP assay revealed that the EZH2/EED was bound to the promotor region of CELF1 within 992 bp upstream of the transcript start site., Conclusion: TUG1 is downregulated in NSCLC. Using TUG1 4C sequencing and bioinformatic analysis, we found CELF1 to be a potential target of TUG1 RNA in in-trans regulation. Moreover, subsequent experiments showed that TUG1 RNA could bind to PRC2 in the promotor region of CELF1 and negatively regulate CELF1 expressions in H520 cells. Our results may facilitate developing new treatment modalities targeting TUG1/PRC2/CELF1 interactions in patients with NSCLC.
- Published
- 2016
- Full Text
- View/download PDF
13. Analysing the mutational status of adenomatous polyposis coli (APC) gene in breast cancer.
- Author
-
Chang YS, Lin CY, Yang SF, Ho CM, and Chang JG
- Abstract
Background: Breast cancer is a heterogeneous disorder for which the underlying genetic basis remains unclear. We developed a method for identifying adenomatous polyposis coli (APC) mutations and we evaluated the possible association between APC genetic variants and breast cancer susceptibility., Methods: Genomic DNA was extracted from tumor and matched peripheral blood samples collected from 89 breast cancer patients and from peripheral blood samples collected from 50 controls. All samples were tested for mutations in exons 1-14 and the mutation cluster region of exon 15 by HRM analysis. All mutations were confirmed by direct DNA sequencing., Results: We identified a new single nucleotide polymorphism (SNP), c.465A>G (K155K), in exon 4 and seven known SNPs: c.573T>C (Y191Y) in exon 5, c.1005A>G (L335L) in exon 9, c.1458T>C (Y486Y) and c.1488A>T (T496T) in exon 11, c.1635G>A (A545A) in exon 13, and c.4479G>A (T1493T) and c.5465T>A (V1822D) in exon 15. The following alterations were found in 2, 1, 2, and 1 patients, respectively: c.465A>G, c.573T>C, c.1005A>G, and c.1488A>T. There was no observed association between breast cancer risk and any of these APC SNPs., Conclusions: APC mutations occur at a low frequency in Taiwanese breast cancer cases. HRM analysis is a powerful method for the detection of APC mutations in breast.
- Published
- 2016
- Full Text
- View/download PDF
14. Arecoline induces TNF-alpha production and Zonula Occludens-1 redistribution in mouse Sertoli TM4 cells.
- Author
-
Kuo TM, Luo SY, Chiang SL, Lee CP, Liu YF, Chang JG, Tsai MH, and Ko YC
- Subjects
- Animals, Arecoline pharmacology, Cell Line, Tumor, Cholinergic Agonists pharmacology, Flavonoids pharmacology, Humans, Infertility, Male chemically induced, Infertility, Male metabolism, Infertility, Male pathology, Male, Mice, Mitogen-Activated Protein Kinase 3 antagonists & inhibitors, Mitogen-Activated Protein Kinase 3 metabolism, Protein Transport drug effects, Sertoli Cells pathology, Arecoline adverse effects, Cholinergic Agonists adverse effects, Gene Expression Regulation drug effects, Sertoli Cells metabolism, Tumor Necrosis Factor-alpha biosynthesis, Zonula Occludens-1 Protein metabolism
- Abstract
Background: Arecoline, a major alkaloid in Areca nut has the ability to induce oxidative stress. The effect of Areca nut, arecoline on reducing sperm quality and quantity were documented previously using several animal models. Junction disruption by down-regulation of the junction-adhesive protein via oxidative stress is an important route mediating abnormal spermatogenesis. Therefore, in this present study, we investigated the functional role of arecoline on junctional proteins., Results: To analyze direct effects of arecoline on testis cells, confluent mouse testicular Sertoli cell line TM4 was exposed to arecoline. Arecoline decreased insoluble zonula occludens-1 (ZO-1) protein expression in TM4 cells, however, arecoline treatment increased TNF-alpha production in both TM4 and monocytic THP1 cells. In addition, ERK1/2 inhibitor PD98059 reversed arecoline effects on TNF-alpha and ZO-1., Conclusions: Arecoline increases the production of TNF-alpha and induces protein redistribution of ZO-1. All these results explain the role of arecoline in male reproductive dysfunction, besides its cytotoxic induction.
- Published
- 2014
- Full Text
- View/download PDF
15. Computational analysis of a novel mutation in ETFDH gene highlights its long-range effects on the FAD-binding motif.
- Author
-
Er TK, Chen CC, Liu YY, Chang HC, Chien YH, Chang JG, Hwang JK, and Jong YJ
- Subjects
- Binding Sites, Child, Computational Biology, Electron-Transferring Flavoproteins genetics, Electron-Transferring Flavoproteins metabolism, Enzyme Activation, Female, Flavin-Adenine Dinucleotide metabolism, Humans, Iron-Sulfur Proteins genetics, Iron-Sulfur Proteins metabolism, Molecular Dynamics Simulation, Multiple Acyl Coenzyme A Dehydrogenase Deficiency etiology, Multiple Acyl Coenzyme A Dehydrogenase Deficiency genetics, Mutation, Oxidoreductases Acting on CH-NH Group Donors genetics, Oxidoreductases Acting on CH-NH Group Donors metabolism, Protein Structure, Tertiary, Electron-Transferring Flavoproteins chemistry, Flavin-Adenine Dinucleotide chemistry, Iron-Sulfur Proteins chemistry, Oxidoreductases Acting on CH-NH Group Donors chemistry
- Abstract
Background: Multiple acyl-coenzyme A dehydrogenase deficiency (MADD) is an autosomal recessive disease caused by the defects in the mitochondrial electron transfer system and the metabolism of fatty acids. Recently, mutations in electron transfer flavoprotein dehydrogenase (ETFDH) gene, encoding electron transfer flavoprotein:ubiquinone oxidoreductase (ETF:QO) have been reported to be the major causes of riboflavin-responsive MADD. To date, no studies have been performed to explore the functional impact of these mutations or their mechanism of disrupting enzyme activity., Results: High resolution melting (HRM) analysis and sequencing of the entire ETFDH gene revealed a novel mutation (p.Phe128Ser) and the hotspot mutation (p.Ala84Thr) from a patient with MADD. According to the predicted 3D structure of ETF:QO, the two mutations are located within the flavin adenine dinucleotide (FAD) binding domain; however, the two residues do not have direct interactions with the FAD ligand. Using molecular dynamics (MD) simulations and normal mode analysis (NMA), we found that the p.Ala84Thr and p.Phe128Ser mutations are most likely to alter the protein structure near the FAD binding site as well as disrupt the stability of the FAD binding required for the activation of ETF:QO. Intriguingly, NMA revealed that several reported disease-causing mutations in the ETF:QO protein show highly correlated motions with the FAD-binding site., Conclusions: Based on the present findings, we conclude that the changes made to the amino acids in ETF:QO are likely to influence the FAD-binding stability.
- Published
- 2011
- Full Text
- View/download PDF
16. Rapid detection of epidermal growth factor receptor mutations with multiplex PCR and primer extension in lung cancer.
- Author
-
Lin CH, Yeh KT, Chang YS, Hsu NC, and Chang JG
- Subjects
- Base Sequence, DNA Primers genetics, Exons, Humans, Polymerase Chain Reaction methods, Polymorphism, Single Nucleotide, Promoter Regions, Genetic, Carcinoma, Non-Small-Cell Lung genetics, DNA Mutational Analysis methods, ErbB Receptors genetics, Lung Neoplasms genetics, Mutation
- Abstract
Epidermal growth factor receptor (EGFR) kinase domain mutations hyperactivate the kinase and confer kinase addiction of the non-small-cell lung cancer (NSCLC) tumor cells. Almost all of these mutations are located within exons 18-21. The -216 single nucleotide polymorphism in the promoter region is associated with increased EGFR production. We present a method for detecting these common mutations in 81 cases of NSCLC. The protocol is based on the multiplex amplification of promoter region and exons 18-21 of the EGFR genes in a single tube, followed by primer extension of the PCR products using various sizes of primers to detect base changes at -216 promoter region and codons 719, 746-750, 790, 858 of the EGFR gene. We compared the results with that from direct sequencing for detecting EGFR mutations in 81 cases of NSCLC. The two methods identified the same 26 mutations, but our method is superior to direct sequencing in terms of the amount of work and time required. We presented a simple and fast method to detect mutations of EGFR genes in NSCLC.
- Published
- 2010
- Full Text
- View/download PDF
17. Fast simultaneous detection of K-RAS mutations in colorectal cancer.
- Author
-
Chang YS, Yeh KT, Chang TJ, Chai C, Lu HC, Hsu NC, and Chang JG
- Subjects
- Codon, Colorectal Neoplasms pathology, DNA Mutational Analysis methods, Humans, Lymphatic Metastasis, Neoplasm Staging, Polymerase Chain Reaction, Sensitivity and Specificity, Colorectal Neoplasms genetics, Genes, ras, Point Mutation
- Abstract
Background: RAS genes acquire the most common somatic gain-of-function mutations in human cancer, and almost all of these mutations are located at codons 12, 13, 61, and 146., Methods: We present a method for detecting these K-RAS hotspot mutations in 228 cases of colorectal cancer. The protocol is based on the multiplex amplification of exons 2, 3 and 4 in a single tube, followed by primer extension of the PCR products using various sizes of primers to detect base changes at codons 12, 13, 61 and 146. We compared the clinicopathological data of colorectal cancer patients with the K-RAS mutation status., Results: K-RAS mutation occurred in 36% (83/228) of our colorectal cancer cases. Univariate analysis revealed a significant association between K-RAS mutation at codon 12 of exon 2 and poor 5-year survival (p = 0.023) and lymph node involvement (p = 0.048). Also, K-RAS mutation at codon 13 of exon 2 correlates with the size of the tumor (p = 0.03). Multivariate analysis adjusted for tumor size, histologic grade, and lymph node metastasis also indicated K-RAS mutations at codon 12 and 13 of exon 2 correlate significantly with overall survival (p = 0.002 and 0.025). No association was observed between codon 61 and 146 and clinicopathological features., Conclusion: We demonstrated a simple and fast way to identify K-RAS mutation.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.